Literature DB >> 27439681

Frontotemporal dementia-related gene mutations in clinical dementia patients from a Chinese population.

Zhihong Shi1,2, Shuai Liu1,2, Lei Xiang1,2, Ying Wang3, Mengyuan Liu1, Shuling Liu1,2, Tong Han4, Yuying Zhou1,2, Jinhuan Wang1,5, Li Cai3, Shuo Gao3, Yong Ji1,2.   

Abstract

Alzheimer's disease (AD) and frontotemporal dementia (FTD) are two common forms of primary neurodegenerative dementia that show overlapping clinical symptoms. The aim of this study was to perform genetic analyses on GRN, VCP, CHMP2B, FUS, TARDBP, C9orf72 and MAPT genes in Chinese AD and FTD patients. We performed gene sequencing of the GRN, VCP, CHMP2B, FUS, TARDBP, MAPT and C9orf72 genes in 61 clinical AD and 38 FTD Chinese patients. We identified a known mutation of MAPT (p.Pro301Leu, c.902C>T) in four patients from an autosomal dominant FTD family with behavioral variant FTD (bvFTD) and progressive nonfluent aphasia (PNFA) phenotypes, and a novel mutation in MAPT (p.Leu48Val, c.142 G>C) in a sporadic progressive supranuclear palsy patient. Two novel variations in VCP (p.Thr127Ala, c. 379A>G; p.Asn401Ser, c.1202A>G) were present in both a sporadic FTD and an AD case, and a novel deletion in GRN (560del p.Leufs) was found in a sporadic primary progressive aphasia patient. Mutations of VCP, GRN and MAPT genes are present in Chinese FTD cases. In the case of the MAPT mutation, the family presented with both bvFTD and PNFA phenotypes, while the VCP mutation was also related to an early-onset AD phenotype.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27439681     DOI: 10.1038/jhg.2016.92

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  34 in total

1.  Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

Authors:  Mariely DeJesus-Hernandez; Ian R Mackenzie; Bradley F Boeve; Adam L Boxer; Matt Baker; Nicola J Rutherford; Alexandra M Nicholson; NiCole A Finch; Heather Flynn; Jennifer Adamson; Naomi Kouri; Aleksandra Wojtas; Pheth Sengdy; Ging-Yuek R Hsiung; Anna Karydas; William W Seeley; Keith A Josephs; Giovanni Coppola; Daniel H Geschwind; Zbigniew K Wszolek; Howard Feldman; David S Knopman; Ronald C Petersen; Bruce L Miller; Dennis W Dickson; Kevin B Boylan; Neill R Graff-Radford; Rosa Rademakers
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

2.  Classification of primary progressive aphasia and its variants.

Authors:  M L Gorno-Tempini; A E Hillis; S Weintraub; A Kertesz; M Mendez; S F Cappa; J M Ogar; J D Rohrer; S Black; B F Boeve; F Manes; N F Dronkers; R Vandenberghe; K Rascovsky; K Patterson; B L Miller; D S Knopman; J R Hodges; M M Mesulam; M Grossman
Journal:  Neurology       Date:  2011-02-16       Impact factor: 9.910

3.  A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia.

Authors:  Chiara Villa; Laura Ghezzi; Anna M Pietroboni; Chiara Fenoglio; Francesca Cortini; Maria Serpente; Claudia Cantoni; Elisa Ridolfi; Alessandra Marcone; Luisa Benussi; Roberta Ghidoni; Francesca Jacini; Andrea Arighi; Giorgio G Fumagalli; Alessandra Mandelli; Giuliano Binetti; Stefano Cappa; Nereo Bresolin; Elio Scarpini; Daniela Galimberti
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

4.  Clinical and neuroimaging characterization of Chinese dementia patients with PSEN1 and PSEN2 mutations.

Authors:  Zhihong Shi; Ying Wang; Shuai Liu; Mengyuan Liu; Shuling Liu; Yuying Zhou; Jinhuan Wang; Li Cai; Ya Ruth Huo; Shuo Gao; Yong Ji
Journal:  Dement Geriatr Cogn Disord       Date:  2014-10-15       Impact factor: 2.959

5.  Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia.

Authors:  S G Mehta; M Khare; R Ramani; G D J Watts; M Simon; K E Osann; S Donkervoort; E Dec; A Nalbandian; J Platt; M Pasquali; A Wang; T Mozaffar; C D Smith; V E Kimonis
Journal:  Clin Genet       Date:  2012-10-04       Impact factor: 4.438

6.  Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia.

Authors:  J S Snowden; S M Pickering-Brown; I R Mackenzie; A M T Richardson; A Varma; D Neary; D M A Mann
Journal:  Brain       Date:  2006-09-26       Impact factor: 13.501

7.  Progranulin-associated primary progressive aphasia: a distinct phenotype?

Authors:  Jonathan D Rohrer; Sebastian J Crutch; Elizabeth K Warrington; Jason D Warren
Journal:  Neuropsychologia       Date:  2010-01       Impact factor: 3.139

8.  The Beijing version of the Montreal Cognitive Assessment as a brief screening tool for mild cognitive impairment: a community-based study.

Authors:  Jing Yu; Juan Li; Xin Huang
Journal:  BMC Psychiatry       Date:  2012-09-25       Impact factor: 3.630

9.  Reliability, validity, and optimal cutoff score of the montreal cognitive assessment (changsha version) in ischemic cerebrovascular disease patients of hunan province, china.

Authors:  Qiu-Yun Tu; Hui Jin; Bin-Rong Ding; Xia Yang; Zeng-Hui Lei; Song Bai; Ying-Dong Zhang; Xiang-Qi Tang
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2013-02-16

10.  Using the Montreal Cognitive Assessment Scale to screen for dementia in Chinese patients with Parkinson's Disease.

Authors:  Ling Chen; Cuiyu Yu; Xiaosu Fu; Weiguo Liu; Ping Hua; Ning Zhang; Shenghan Kuo
Journal:  Shanghai Arch Psychiatry       Date:  2013-10
View more
  9 in total

Review 1.  Multisystem Proteinopathy Due to VCP Mutations: A Review of Clinical Heterogeneity and Genetic Diagnosis.

Authors:  Gerald Pfeffer; Grace Lee; Carly S Pontifex; Roberto D Fanganiello; Allison Peck; Conrad C Weihl; Virginia Kimonis
Journal:  Genes (Basel)       Date:  2022-05-27       Impact factor: 4.141

2.  Recent advances in the genetics of frontotemporal dementia.

Authors:  Daniel W Sirkis; Ethan G Geier; Luke W Bonham; Celeste M Karch; Jennifer S Yokoyama
Journal:  Curr Genet Med Rep       Date:  2019-01-30

Review 3.  Mutations in the Human AAA+ Chaperone p97 and Related Diseases.

Authors:  Wai Kwan Tang; Di Xia
Journal:  Front Mol Biosci       Date:  2016-12-01

4.  Updated meta-analysis of the role of APOE ε2/ε3/ε4 alleles in frontotemporal lobar degeneration.

Authors:  Wen-Hua Su; Zhi-Hong Shi; Shu-Ling Liu; Xiao-Dan Wang; Shuai Liu; Yong Ji
Journal:  Oncotarget       Date:  2017-07-04

5.  A Longitudinal Study of a Chinese Man Presenting with Non-Fluent/Agrammatic Variant of Primary Progressive Aphasia.

Authors:  Xiaoyan Liu; Fangping He; Zhongqin Chen; Ping Liu; Guoping Peng
Journal:  Front Neurol       Date:  2018-02-16       Impact factor: 4.003

6.  The Right Temporal Variant of Frontotemporal Dementia Is Not Genetically Sporadic: A Case Series.

Authors:  Hulya Ulugut Erkoyun; Sven J van der Lee; Bas Nijmeijer; Rosalina van Spaendonk; Anne Nelissen; Marta Scarioni; Anke Dijkstra; Bedia Samancı; Hakan Gürvit; Zerrin Yıldırım; Fatih Tepgeç; Basar Bilgic; Frederik Barkhof; Annemieke Rozemuller; Wiesje M van der Flier; Philip Scheltens; Petra Cohn-Hokke; Yolande Pijnenburg
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 7.  Valosin Containing Protein (VCP): A Multistep Regulator of Autophagy.

Authors:  Veronica Ferrari; Riccardo Cristofani; Barbara Tedesco; Valeria Crippa; Marta Chierichetti; Elena Casarotto; Marta Cozzi; Francesco Mina; Margherita Piccolella; Mariarita Galbiati; Paola Rusmini; Angelo Poletti
Journal:  Int J Mol Sci       Date:  2022-02-09       Impact factor: 5.923

8.  The Frequency of Genetic Mutations Associated With Behavioral Variant Frontotemporal Dementia in Chinese Han Patients.

Authors:  Li Liu; Bo Cui; Min Chu; Yue Cui; Donglai Jing; Dan Li; Kexin Xie; Yu Kong; Tianxinyu Xia; Chaodong Wang; Liyong Wu
Journal:  Front Aging Neurosci       Date:  2021-07-08       Impact factor: 5.750

9.  The role of MAPT gene in Chinese dementia patients: a P301L pedigree study and brief literature review.

Authors:  Shuang He; Shuai Chen; Ming-Rong Xia; Zhi-Kun Sun; Yue Huang; Jie-Wen Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2018-06-18       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.